A Novel Insight into Paraptosis-Related Classification and Signature in Lower-Grade Gliomas

Lower-grade gliomas (LGG) are the most common intracranial malignancies that readily evolve to high-grade gliomas and increase drug resistance. Paraptosis is defined as a nonapoptotic form of programmed cell death, which is gradually focused on patients with gliomas to develop treatment options. How...

Full description

Saved in:
Bibliographic Details
Main Authors: Xi-Feng Qian, Jia-Hao Zhang, Yue-Xue Mai, Xin Yin, Yu-Bin Zheng, Zi-Yuan Yu, Guo-Dong Zhu, Xu-Guang Guo
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:International Journal of Genomics
Online Access:http://dx.doi.org/10.1155/2022/6465760
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552816438149120
author Xi-Feng Qian
Jia-Hao Zhang
Yue-Xue Mai
Xin Yin
Yu-Bin Zheng
Zi-Yuan Yu
Guo-Dong Zhu
Xu-Guang Guo
author_facet Xi-Feng Qian
Jia-Hao Zhang
Yue-Xue Mai
Xin Yin
Yu-Bin Zheng
Zi-Yuan Yu
Guo-Dong Zhu
Xu-Guang Guo
author_sort Xi-Feng Qian
collection DOAJ
description Lower-grade gliomas (LGG) are the most common intracranial malignancies that readily evolve to high-grade gliomas and increase drug resistance. Paraptosis is defined as a nonapoptotic form of programmed cell death, which is gradually focused on patients with gliomas to develop treatment options. However, the specific role of paraptosis in LGG and its correlation is still vague. In this study, we first establish the novel paraptosis-based prognostic model for LGG patients. The relevant data of LGG patients were acquired from The Cancer Genome Atlas database, and we found that LGG patients could be divided into three different clusters based on paraptosis via consensus cluster analysis. Through least absolute shrinkage and selection operator regression analysis and multivariate Cox regression analysis, 10-paraptosis-related gene (PRG) signatures (CDK4, TNK2, DSTYK, CDKN3, CCR4, CASP9, HSPA5, RGR, LPAR1, and PDCD6IP) were identified to separate LGG patients into high- and low-risk subgroups successfully. The Kaplan–Meier analysis and time-dependent receiver-operating characteristic showed that the performances of predicting overall survival (OS) were dramatically high. The parallel results were reappeared and verified by using the Chinese Glioma Genome Atlas and Gene Expression Omnibus databases. Independent prognostic analysis and nomogram construction implied that risk scores could be considered the independent factor to predict OS. Enrichment analysis indicated that immune-related biological processes were generally enriched, and different immune statuses were highly infiltrated in high-risk group. We also confirmed the potential relationship of 10-PRG signatures and drug sensitivity of Food and Drug Administration–approved drugs. In summary, our findings provide a novel knowledge of paraptosis status and crucial direction to further explore the role of PRG signatures in LGG.
format Article
id doaj-art-e55227d6171a44d0a2d87cd634998df6
institution Kabale University
issn 2314-4378
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series International Journal of Genomics
spelling doaj-art-e55227d6171a44d0a2d87cd634998df62025-02-03T05:57:54ZengWileyInternational Journal of Genomics2314-43782022-01-01202210.1155/2022/6465760A Novel Insight into Paraptosis-Related Classification and Signature in Lower-Grade GliomasXi-Feng Qian0Jia-Hao Zhang1Yue-Xue Mai2Xin Yin3Yu-Bin Zheng4Zi-Yuan Yu5Guo-Dong Zhu6Xu-Guang Guo7Department of Clinical Laboratory MedicineDepartment of Clinical Laboratory MedicineDepartment of Clinical Laboratory MedicineDepartment of Clinical Laboratory MedicineDepartment of Clinical Laboratory MedicineDepartment of Clinical Laboratory MedicineDepartment of OncologyDepartment of Clinical Laboratory MedicineLower-grade gliomas (LGG) are the most common intracranial malignancies that readily evolve to high-grade gliomas and increase drug resistance. Paraptosis is defined as a nonapoptotic form of programmed cell death, which is gradually focused on patients with gliomas to develop treatment options. However, the specific role of paraptosis in LGG and its correlation is still vague. In this study, we first establish the novel paraptosis-based prognostic model for LGG patients. The relevant data of LGG patients were acquired from The Cancer Genome Atlas database, and we found that LGG patients could be divided into three different clusters based on paraptosis via consensus cluster analysis. Through least absolute shrinkage and selection operator regression analysis and multivariate Cox regression analysis, 10-paraptosis-related gene (PRG) signatures (CDK4, TNK2, DSTYK, CDKN3, CCR4, CASP9, HSPA5, RGR, LPAR1, and PDCD6IP) were identified to separate LGG patients into high- and low-risk subgroups successfully. The Kaplan–Meier analysis and time-dependent receiver-operating characteristic showed that the performances of predicting overall survival (OS) were dramatically high. The parallel results were reappeared and verified by using the Chinese Glioma Genome Atlas and Gene Expression Omnibus databases. Independent prognostic analysis and nomogram construction implied that risk scores could be considered the independent factor to predict OS. Enrichment analysis indicated that immune-related biological processes were generally enriched, and different immune statuses were highly infiltrated in high-risk group. We also confirmed the potential relationship of 10-PRG signatures and drug sensitivity of Food and Drug Administration–approved drugs. In summary, our findings provide a novel knowledge of paraptosis status and crucial direction to further explore the role of PRG signatures in LGG.http://dx.doi.org/10.1155/2022/6465760
spellingShingle Xi-Feng Qian
Jia-Hao Zhang
Yue-Xue Mai
Xin Yin
Yu-Bin Zheng
Zi-Yuan Yu
Guo-Dong Zhu
Xu-Guang Guo
A Novel Insight into Paraptosis-Related Classification and Signature in Lower-Grade Gliomas
International Journal of Genomics
title A Novel Insight into Paraptosis-Related Classification and Signature in Lower-Grade Gliomas
title_full A Novel Insight into Paraptosis-Related Classification and Signature in Lower-Grade Gliomas
title_fullStr A Novel Insight into Paraptosis-Related Classification and Signature in Lower-Grade Gliomas
title_full_unstemmed A Novel Insight into Paraptosis-Related Classification and Signature in Lower-Grade Gliomas
title_short A Novel Insight into Paraptosis-Related Classification and Signature in Lower-Grade Gliomas
title_sort novel insight into paraptosis related classification and signature in lower grade gliomas
url http://dx.doi.org/10.1155/2022/6465760
work_keys_str_mv AT xifengqian anovelinsightintoparaptosisrelatedclassificationandsignatureinlowergradegliomas
AT jiahaozhang anovelinsightintoparaptosisrelatedclassificationandsignatureinlowergradegliomas
AT yuexuemai anovelinsightintoparaptosisrelatedclassificationandsignatureinlowergradegliomas
AT xinyin anovelinsightintoparaptosisrelatedclassificationandsignatureinlowergradegliomas
AT yubinzheng anovelinsightintoparaptosisrelatedclassificationandsignatureinlowergradegliomas
AT ziyuanyu anovelinsightintoparaptosisrelatedclassificationandsignatureinlowergradegliomas
AT guodongzhu anovelinsightintoparaptosisrelatedclassificationandsignatureinlowergradegliomas
AT xuguangguo anovelinsightintoparaptosisrelatedclassificationandsignatureinlowergradegliomas
AT xifengqian novelinsightintoparaptosisrelatedclassificationandsignatureinlowergradegliomas
AT jiahaozhang novelinsightintoparaptosisrelatedclassificationandsignatureinlowergradegliomas
AT yuexuemai novelinsightintoparaptosisrelatedclassificationandsignatureinlowergradegliomas
AT xinyin novelinsightintoparaptosisrelatedclassificationandsignatureinlowergradegliomas
AT yubinzheng novelinsightintoparaptosisrelatedclassificationandsignatureinlowergradegliomas
AT ziyuanyu novelinsightintoparaptosisrelatedclassificationandsignatureinlowergradegliomas
AT guodongzhu novelinsightintoparaptosisrelatedclassificationandsignatureinlowergradegliomas
AT xuguangguo novelinsightintoparaptosisrelatedclassificationandsignatureinlowergradegliomas